健保藥品的HTA評估報告
- 161 Ninlaro Capsules 4mg、3mg、2.3mg
- 162 Kyprolis for Injection
- 163 Fluzole powder for oral suspension 40mg/mL
- 164 Curosurf® Endotracheobronchial Suspension
- 165 血甯博皮下注射劑 30 毫克/毫升、150 毫克/毫升(Hemlibra SC injection 30mg/mL、150mg/mL)
- 166 吉他韋膜衣錠 (Biktarvy Tablets)
- 167 滋若愷膜衣錠 (Juluca film coated tablets)
- 168 杜避炎注射劑 300 毫克(DUPIXENT solution for injection 300mg)
- 169 癌必定膜衣錠 20 毫克、40 毫克及60 毫克 (Cabometyx film-coated tablet 20 mg、40 mg、60 mg)
- 170 沛斯博凍晶注射劑 1 毫克 (BESPONSA 1 mg Powder for Concentrate for Solution for Infusion)